https://www.fortunebusinessinsights.com/ophthalmic-ultrasound-market-113237
https://www.fortunebusinessinsights.com/ophthalmic-ultrasound-market-113237
The global ophthalmic ultrasound market was valued at USD 283.9 million in 2024 and is projected to
reach USD 303.7 million in 2025, growing to USD 499.6 million by 2032. This reflects a compound annual
growth rate (CAGR) of 7.4% over the forecast period. In 2024, North America led the ophthalmic
ultrasound market, accounting for 42.40% of the total market share.
The ophthalmic ultrasound market is witnessing notable growth, driven by increasing demand for
accurate and early diagnosis of eye diseases. Advancements in portable and hand-held devices are
enhancing accessibility and usability, especially in remote and resource-limited settings. Rising adoption
of 3D imaging technology is significantly improving diagnostic precision and surgical planning.
Additionally, the expansion of ophthalmic clinics and strategic collaborations among hospitals are further
supporting market growth. As awareness of ocular health increases globally, the ophthalmic ultrasound
market is expected to continue its upward trajectory across various product, imaging, and end-user
segments.
Continue reading for more details:
https://www.fortunebusinessinsights.com/ophthalmic-ultrasound-market-113237
Market Segmentation
• By product type, the Ophthalmic Ultrasound Market is segmented into A-scan, B-scan, combined
scan, pachymeter, and ultrasound biomicroscope.
• Based on mobility, the market is divided into standalone and portable devices.
• By end user, the Ophthalmic Ultrasound Market serves hospitals, eye clinics, and ambulatory
surgical centers.
• Applications include diagnosis of intraocular tumors, measurement of ocular dimensions, and
detection of retinal detachment.
• Geographical segmentation includes North America, Europe, Asia Pacific, Latin America, and the
Middle East & Africa.
List Of Key Ophthalmic Ultrasound Companies Profiled:
• Keeler (U.K.)
• HAI Laboratories, Inc. (U.S.)
• Micro Medical Devices (MMD), Inc. (U.S.)
• Lumibird Medical (France)
• NIDEK CO., LTD. (Japan)
• Sonomed Escalon (U.S.)
• DGH Technology, Inc. (U.S.)
Market Growth
• The Ophthalmic Ultrasound Market is growing steadily due to rising demand for accurate and non-
invasive diagnostic imaging in ophthalmology.
•
Increasing prevalence of cataracts, glaucoma, retinal disorders, and ocular tumors is fueling
Ophthalmic Ultrasound Market adoption.
• Technological advancements in A-scan, B-scan, and combined mode devices are enhancing
diagnostic accuracy and efficiency.
• Growing geriatric population and higher awareness about preventive eye care are key contributors
to market expansion.
•
Integration of portable and handheld devices is creating new opportunities in the Ophthalmic
Ultrasound Market for point-of-care diagnostics.
Restraining Factors
• High device costs and limited reimbursement in certain regions hinder Ophthalmic Ultrasound
Market growth.
•
Lack of skilled professionals to operate ophthalmic ultrasound devices reduces adoption in smaller
clinics.
•
Limited access to advanced equipment in developing countries restricts market penetration.
• Competition from alternative imaging technologies like OCT poses a challenge to the Ophthalmic
Ultrasound Market.
• Frequent calibration and maintenance requirements increase operational costs for healthcare
providers.
Regional Analysis
• North America dominates the Ophthalmic Ultrasound Market due to advanced healthcare
infrastructure, high awareness, and early adoption of diagnostic innovations.
• Europe shows strong market demand driven by a high number of eye care facilities and regular
screening programs.
• Asia Pacific is witnessing the fastest growth in the Ophthalmic Ultrasound Market due to rising
incidences of vision disorders and expanding healthcare access.
•
Latin America is experiencing gradual adoption supported by growing investments in ophthalmology.
• Middle East & Africa presents future potential with increasing focus on improving eye care services
and diagnostic capabilities.